IN2014DN09780A - - Google Patents

Info

Publication number
IN2014DN09780A
IN2014DN09780A IN9780DEN2014A IN2014DN09780A IN 2014DN09780 A IN2014DN09780 A IN 2014DN09780A IN 9780DEN2014 A IN9780DEN2014 A IN 9780DEN2014A IN 2014DN09780 A IN2014DN09780 A IN 2014DN09780A
Authority
IN
India
Prior art keywords
event
vitamins
vitamin
organism
per day
Prior art date
Application number
Other languages
English (en)
Inventor
Villorij Ivanovich Strukov
Olga Jhones
Evgenij Nikolaevich Krutiakov
Konstantin Gennadevich ELISTRATOV
Original Assignee
Obschestvo S Ogranichennoj Otvetstvennost Ju Parafarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoj Otvetstvennost Ju Parafarm filed Critical Obschestvo S Ogranichennoj Otvetstvennost Ju Parafarm
Publication of IN2014DN09780A publication Critical patent/IN2014DN09780A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
IN9780DEN2014 2012-04-19 2014-11-19 IN2014DN09780A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (1)

Publication Number Publication Date
IN2014DN09780A true IN2014DN09780A (enrdf_load_stackoverflow) 2015-07-31

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9780DEN2014 IN2014DN09780A (enrdf_load_stackoverflow) 2012-04-19 2014-11-19

Country Status (17)

Country Link
US (1) US9827273B2 (enrdf_load_stackoverflow)
EP (1) EP2845598B1 (enrdf_load_stackoverflow)
JP (1) JP6286417B2 (enrdf_load_stackoverflow)
CN (1) CN104736161B (enrdf_load_stackoverflow)
AU (1) AU2012377476B2 (enrdf_load_stackoverflow)
BR (1) BR112014025990B1 (enrdf_load_stackoverflow)
CA (1) CA2870823C (enrdf_load_stackoverflow)
DK (1) DK2845598T3 (enrdf_load_stackoverflow)
EA (1) EA026533B1 (enrdf_load_stackoverflow)
ES (1) ES2616035T3 (enrdf_load_stackoverflow)
IL (1) IL235169B (enrdf_load_stackoverflow)
IN (1) IN2014DN09780A (enrdf_load_stackoverflow)
LT (1) LT2845598T (enrdf_load_stackoverflow)
PL (1) PL2845598T3 (enrdf_load_stackoverflow)
RU (1) RU2497533C1 (enrdf_load_stackoverflow)
UA (1) UA111536C2 (enrdf_load_stackoverflow)
WO (1) WO2013157982A1 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
CA2526845A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
MX2010008906A (es) * 2008-02-13 2010-11-05 Dsm Ip Assets Bv Uso combinado de 25-hidroxi-vitamina d3 y vitamina d3 para mejorar la densidad mineral osea y para tratar osteoporosis.
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
CA2870823C (en) 2017-10-03
AU2012377476A8 (en) 2014-12-18
CA2870823A1 (en) 2013-10-24
EP2845598B1 (en) 2017-01-04
ES2616035T3 (es) 2017-06-09
JP2015516974A (ja) 2015-06-18
EP2845598A4 (en) 2015-10-28
IL235169A0 (en) 2014-12-31
EA201401155A1 (ru) 2015-05-29
UA111536C2 (uk) 2016-05-10
LT2845598T (lt) 2017-02-27
US9827273B2 (en) 2017-11-28
AU2012377476B2 (en) 2017-10-05
IL235169B (en) 2019-10-31
CN104736161B (zh) 2021-07-06
BR112014025990B1 (pt) 2021-02-17
PL2845598T3 (pl) 2017-07-31
WO2013157982A1 (ru) 2013-10-24
DK2845598T3 (en) 2017-04-10
US20150224150A1 (en) 2015-08-13
CN104736161A (zh) 2015-06-24
EP2845598A1 (en) 2015-03-11
RU2497533C1 (ru) 2013-11-10
AU2012377476A1 (en) 2014-12-11
JP6286417B2 (ja) 2018-02-28
BR112014025990A2 (pt) 2017-06-27
EA026533B1 (ru) 2017-04-28

Similar Documents

Publication Publication Date Title
IN2014DN09780A (enrdf_load_stackoverflow)
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
NZ617397A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units
IN2014DN09779A (enrdf_load_stackoverflow)
MX2013003523A (es) Composicion farmaceutica de dosis baja.
JP2016047856A (ja) カルシウムで骨空洞形成を充填するための組成物、その組成物の使用、および組み合わせ
JOP20170044B1 (ar) تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو
PH12020500606A1 (en) Use of functionalized calcium carbonate as active ingredient
Maksimyuk et al. Strontium ranelate in treatment of postmenopausal osteoporosis
UA85494C2 (ru) Фармацевтическая композиция для лечения заболеваний костной ткани
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
UA85160U (uk) Спосіб лікування гострого атрофічного кандидозу слизової оболонки порожнини рота у хворих на цукровий діабет
MD667Y (en) Method for treatment of infectious mononucleosis in children
NZ619215B2 (en) Method for filling bone cavities with calcium